The effect of autologous serum drops on keratopathy in patients hospitalized in intensive care unit

Effect of autologous serum drop on the occurrence of exposure keratopathy in patients hospitalized intensive care units

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161210031328N9

Enrollment

Registered

2019-04-10

Start date

2018-12-11

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratopathy. Unspecified disorder of cornea

Interventions

Intervention 1: Intervention group: The right eye will be considered as intervention group. In addition to routine care, autologous serum drops are cast in the right eye every six hours. In order to p

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Hospitalization in intensive care unit 16 - 65 years old Signing the consent form Awareness score less than 10 according to Glasgow Coma Scale No history of eye disease before hospitalization Non-traumatic face and eye No history of consumption of ointment and ocular drops before hospitalization

Exclusion criteria

Exclusion criteria: Unwillingness to participating in the study

Design outcomes

Primary

Measure	Time frame
Exposure keratopathy. Timepoint: Examination of the eye before study, using fluorescein paper and ophthalmoscope with blue cobalt light filter, and then daily and at the beginning of each day. Method of measurement: The scale of corneal changes.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahbobeh Sajadi

Arak University of Medical Sciences

sajadimahbobeh@yahoo.com+98 86 3417 3505

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026